Altimmune to Participate in the Leerink Global Healthcare Conference
Altimmune (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, has announced its upcoming participation in the Leerink Global Healthcare Conference in March 2025. The company's management team will engage in a fireside chat session during the conference.
The event will be accessible via webcast through the Events section of the Altimmune website, providing investors and interested parties an opportunity to follow the discussion remotely.
Altimmune (Nasdaq: ALT), un'azienda biofarmaceutica in fase clinica avanzata, ha annunciato la sua prossima partecipazione alla Leerink Global Healthcare Conference a marzo 2025. Il team di gestione dell'azienda parteciperà a una sessione di chat informale durante la conferenza.
L'evento sarà accessibile tramite webcast nella sezione Eventi del sito web di Altimmune, offrendo agli investitori e alle parti interessate l'opportunità di seguire la discussione da remoto.
Altimmune (Nasdaq: ALT), una empresa biofarmacéutica en etapa clínica avanzada, ha anunciado su próxima participación en la Leerink Global Healthcare Conference en marzo de 2025. El equipo de gestión de la empresa participará en una sesión de charla informal durante la conferencia.
El evento será accesible a través de un webcast en la sección de Eventos del sitio web de Altimmune, brindando a los inversores y partes interesadas la oportunidad de seguir la discusión de forma remota.
Altimmune (Nasdaq: ALT), 후기 임상 단계의 바이오제약 회사,는 2025년 3월에 열리는 Leerink Global Healthcare Conference에 참가할 예정이라고 발표했습니다. 회사의 경영진은 컨퍼런스 중에 편안한 대화 세션에 참여할 것입니다.
이 행사는 Altimmune 웹사이트의 이벤트 섹션을 통해 웹캐스트로 접속할 수 있어 투자자와 관심 있는 분들이 원격으로 논의를 따라갈 수 있는 기회를 제공합니다.
Altimmune (Nasdaq: ALT), une entreprise biopharmaceutique en phase clinique avancée, a annoncé sa prochaine participation à la Leerink Global Healthcare Conference en mars 2025. L'équipe de direction de l'entreprise participera à une session de discussion informelle pendant la conférence.
L'événement sera accessible par webdiffusion via la section Événements du site Web de Altimmune, offrant aux investisseurs et aux parties intéressées la possibilité de suivre la discussion à distance.
Altimmune (Nasdaq: ALT), ein biopharmazeutisches Unternehmen in der späten klinischen Phase, hat seine bevorstehende Teilnahme an der Leerink Global Healthcare Conference im März 2025 angekündigt. Das Management-Team des Unternehmens wird während der Konferenz an einer informellen Gesprächsrunde teilnehmen.
Die Veranstaltung wird über einen Webcast im Bereich Veranstaltungen der Altimmune-Website zugänglich sein, was Investoren und Interessierten die Möglichkeit bietet, die Diskussion aus der Ferne zu verfolgen.
- None.
- None.
GAITHERSBURG, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Leerink Global Healthcare Conference. Details are as follows:
| Conference: | Leerink Global Healthcare Conference |
| Date/Time: | Monday, March 10, 2025, at 3:40 p.m. EST |
The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.
About Altimmune
Altimmune is a late clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.
Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter
Company Contact:
Greg Weaver
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com
Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com
Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com
This press release was published by a CLEAR® Verified individual.
FAQ
When is Altimmune (ALT) participating in the Leerink Global Healthcare Conference?
How can investors access Altimmune's (ALT) fireside chat at the Leerink Conference?
What type of presentation will Altimmune (ALT) give at the Leerink Global Healthcare Conference?
What is Altimmune's (ALT) current development stage as a company?
